Active Ingredient History
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arthritis, Rheumatoid (approved 2001)
Allergy and Immunology (Phase 1)
Amyotrophic Lateral Sclerosis (Phase 2)
Anterior Cruciate Ligament Injuries (Phase 2)
Anti-Inflammatory Agents (Phase 2)
Arthritis (Phase 2)
Arthritis, Juvenile (Phase 3)
Arthritis, Rheumatoid (Phase 4)
Arthropathy, Neurogenic (Phase 1/Phase 2)
Asthma (Phase 1/Phase 2)
Autoimmune Diseases (Phase 2)
Biological Therapy (Phase 2)
Blepharitis (Phase 1/Phase 2)
Brain Injuries, Traumatic (Phase 2)
Breast Neoplasms (Phase 1)
Cerebral Hemorrhage (Phase 2)
Child (Phase 2)
Colorectal Neoplasms (Phase 2)
Community-Acquired Infections (Phase 2)
Conjunctivitis (Phase 1)
Corneal Neovascularization (Phase 1/Phase 2)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2/Phase 3)
Cortisone (Phase 3)
COVID-19 (Phase 3)
Cryopyrin-Associated Periodic Syndromes (Phase 2)
Cystic Fibrosis (Phase 2)
Cytokine Release Syndrome (Phase 3)
Dengue (Phase 2)
Dengue Virus (Phase 2)
Dermatitis, Allergic Contact (Phase 3)
Dermatitis, Atopic (Phase 1)
Dermatology (Phase 2)
Dermatomyositis (Phase 2/Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Drugs, Investigational (Phase 3)
Eczema (Phase 1)
Endometriosis (Early Phase 1)
Familial Mediterranean Fever (Phase 3)
Fatigue (Phase 2)
Fatigue Syndrome, Chronic (Phase 2/Phase 3)
Giant Cell Arteritis (Phase 3)
Gout (Phase 2/Phase 3)
Granulomatous Disease, Chronic (Early Phase 1)
Healthcare-Associated Pneumonia (Phase 2)
Healthy Volunteers (Phase 1)
Hearing Loss, Sensorineural (Phase 1/Phase 2)
Hearing Loss, Sudden (Phase 1/Phase 2)
Heart Diseases (Phase 2/Phase 3)
Heart Failure (Phase 2/Phase 3)
Heart Failure, Diastolic (Phase 2)
Heart Failure, Systolic (Phase 2)
Hemorrhage (Phase 2)
Hepatitis, Alcoholic (Phase 2/Phase 3)
Hidradenitis Suppurativa (Phase 2)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 2)
Hyperinsulinism (Phase 2)
Hypertension, Pulmonary (Phase 1/Phase 2)
Hypoglycemia (Phase 2)
Hypogonadism (Phase 3)
Immune System Diseases (Phase 1/Phase 2)
Immunomodulation (Phase 2)
Infant, Premature, Diseases (Phase 1/Phase 2)
Inflammation (Phase 2/Phase 3)
Insulin Resistance (Phase 2)
Kidney Failure, Chronic (Phase 2)
Kidney Transplantation (Phase 2)
Knee Injuries (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 1/Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Macrophage Activation Syndrome (Phase 2)
Meniere Disease (Phase 2)
Metabolic Diseases (Phase 2)
Metabolic Syndrome (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Mucopolysaccharidosis III (Phase 2/Phase 3)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 1/Phase 2)
Myocardial Infarction (Phase 2/Phase 3)
Myositis, Inclusion Body (Phase 2/Phase 3)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1)
Nervous System Diseases (Phase 1)
Nervous System Malformations (Phase 1/Phase 2)
Neurotoxicity Syndromes (Phase 2)
Obesity (Phase 3)
Osteoarthritis (Phase 2)
Pain (Phase 1)
Pancreatic Neoplasms (Phase 2)
Papilledema (Phase 1/Phase 2)
Pericarditis (Phase 4)
Pneumonia (Phase 2/Phase 3)
Polycystic Ovary Syndrome (Phase 2)
Polymyositis (Phase 2/Phase 3)
Post-Acute COVID-19 Syndrome (Phase 2/Phase 3)
Prediabetic State (Phase 2)
Psoriasis (Phase 2)
Pulmonary Arterial Hypertension (Phase 1)
Rectal Neoplasms (Phase 1)
Renal Insufficiency, Chronic (Phase 2/Phase 3)
Respiratory Distress Syndrome (Phase 2)
Respiratory Tract Infections (Phase 2)
Rheumatology (Phase 2)
SARS-CoV-2 (Phase 2/Phase 3)
Sepsis (Phase 2/Phase 3)
Severe Dengue (Phase 2)
Sjogren's Syndrome (Phase 2)
Sneddon Syndrome (Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Still's Disease, Adult-Onset (Phase 3)
Subarachnoid Hemorrhage (Phase 3)
Urticaria (Phase 1/Phase 2)
Uveitis (Phase 2)
Ventilators, Mechanical (Phase 2)
Virus Diseases (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
